Rasilez aliskiren regulatory update

Japan's Ministry of Health, Labor and Welfare (MHLW) approved Rasilez aliskiren to treat hypertension. The renin inhibitor, which is marketed in the U.S. as Tekturna, is approved in over 70 countries...